BioUtah News
-
Fluidx Unveils New Embolic for Neurovascular Use
New Catheter-Delivered Embolic Shows Promise for Treating Life-Threatening Bleeding around the Brain
-
Nomi Health Hires Global Health and Technology Leader Amy Wykoff as Company’s First Chief Product Officer
Wykoff to build upon more than two decades of public and private sector healthcare leadership to head up…
-
IONIQ is “Clinical Diagnostics Solution of the Year 2022”
IONIQ is “Clinical Diagnostics Solution of the Year 2022”
-
IONIQ Science 2022 year-end update
For IONIQ Sciences, 2022 was another big year. As we respond to the FDA’s substantive review of our De Novo…
-
2022 BIO Report Ranks Utah in the Top Eight States for Bioscience Specialization
The 2022 TEConomy/BIO report, The US Bioscience Industry: Fostering Innovation and Driving America’s Economy Forward, examines the bioscience industry’s…
-
Participate in Life Sciences Day on the Hill
The annual Life Sciences Day on the Hill provides our industry with the opportunity to get face time…
-
Stryker launches state-of-the-art Neurovascular R&D lab with advanced technology to accelerate stroke care innovation
Stryker, one of the world’s leading medical technology companies, recently opened its Neurovascular (NV) lab, a state-of-the-art lab…
-
Merrimack provides Ipsen report that Onivyde® regimen demonstrated statistically significant improvement in overall survival in previously untreated metastatic pancreatic ductal adenocarcinoma
Cambridge, MA, November 9, 2022 /Business Wire/ – Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] announced…
-
Utah Life Sciences Companies participate in Utah Trade Delegation to Medica 2022
Exhibiting their innovative products and services to over 80,000 visitors, 11 life science companies represented Utah at the MEDICA…
-
Halia Therapeutics Presents at 4th Inflammasome Therapeutics Summit
SALT LAKE CITY–(BUSINESS WIRE)–Halia Therapeutics, a clinical stage biopharmaceutical company advancing innovative medicines to treat diseases driven by…
-
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
LONDON and SALT LAKE CITY, Nov. 30, 2022 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an…
-
Ortho Development Launches Enabling Technology for Total Knee
by Julie A. Vetalice Ortho Development BKS Total PSI has been released for commercial distribution in the United…
-
Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition
Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654
-
NEW DIGITAL HEALTH INITIATIVE TO CREATE NEXT GENERATION OF MEDICAL APPS, GAMES, AND TECHNOLOGIES
The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE
-
Teva Announces Appointment of Richard Francis as President and CEO
Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future
-
Myriad Genetics Announces UroSuite™, an Industry-First Suite of Genetic Tests for Prostate Cancer, Giving Urologists Access to Timely, Data-driven Medical Information
SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
-
CenExel Creates Clinical Sciences Business Unit
CenExel announces a new Clinical Sciencesbusiness unit and more.
-
BioHive Summit Recap
On Thursday, November 10, 2022, the BioHIve gathered at the Salt Palace for the annual BioHive Summit presented…
-
Betty Iverson Retirement
Betty Iverson Retirement Announced
-
PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update
PolarityTE provided a business update and reported financial results for the quarterly period ended September 30, 2022.
-
PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company
PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer…
-
Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland
Clene announced that it has entered into a securities purchase agreement with certain existing stockholders.
-
Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial
The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24…
-
Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test
$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.
-
Myriad Genetics Reports Third Quarter Financial Results
Myriad Genetics announced financial results for its third quarter ended September 30, 2022 and provided an update on…
-
Renalytix Reports Full Year Fiscal 2022 Results
Renalytix announced its full year results for the twelve months ended 30 June 2022.
-
Merit Medical Reports Results for Quarter Ended September 30, 2022
Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.
-
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
-
KidneyIntelX Medicare Update
Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims…
-
15th Annual 2022 Women Tech Award Recipients
The Women’s Tech Council announced eight award recipients from its twenty one finalists.
-
Geneial Receives $2.3M NIH Grant
Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development…
-
SINTX TECHNOLOGIES AWARDED DEPARTMENT OF ENERGY GRANT FOR DEVELOPMENT OF 3D PRINTED CERAMIC HEAT EXCHANGERS
SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy…
-
NATIONAL INSTITUTES OF HEALTH AWARDS GRANT TO SINTX TECHNOLOGIES FOR DEVELOPMENT OF 3D PRINTED ANTIMICROBIAL TRAUMA DEVICE
SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop…
-
Brandy Isaacks Joins CenExel as Vice President of Project Management & Scientific Affairs
CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations
-
Foldax Appoints Gregory D. Casciaro as Chief Executive Officer
Foldax announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective…
-
KidneyIntelX Clinical Utility and Health Economics Validated in Multiple Data Releases at American Society of Nephrology
Four presentations, including first clinical utility findings from multi-year real world evidence results from a major healthcare system…
-
EVŌQ Bio is Fielding Partnership Inquiries for its Antimicrobial Medical Materials Additives at the MedTech Conference
Attendance at premiere medical technology convention to spur partnership, growth opportunities. SALT LAKE CITY, October 10, 2022 /PRNewswire/…
-
Owlet Announces FDA 510(k) Submission for Prescription Pediatric Monitor
LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (NYSE: OWLT) (the “Company”) announces that it has submitted a 510(k) premarket notification…
-
Phoenix PharmaLabs Awarded $8.7 Million Grant from NIDA to Study Compound for Treatment of Cocaine Use Disorder
Woods Cross, UT (October 6, 2022) – Phoenix PharmaLabs, Inc. (https://phoenixpharmalabs.com), a private company developing potent, non-addictive treatments…
-
Xenter, the World’s First “TechMed” Company, Unveils the XenFI Wireless Network
Xenter unveiled XenFI™, the first product in its wireless “Technology in Medicine” ecosystem.
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
